Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-062 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
filingDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017531626-A |
titleOfInvention |
Fungal glucosylceramide as a vaccine for fungal infections |
abstract |
The invention features a composition comprising a fungal glucosylceramide (GlcCer) purified from a non-pathogenic fungus (eg, Candida utilis) and optionally an adjuvant. The invention also features a method for treating a patient having a fungal disease and a method for preventing a fungal disease in a subject by administration of these compositions. Also, (a) providing a fungal glucosylceramide isolated from a non-pathogenic fungus; and (b) mixing the fungal glucosylceramide with an adjuvant in a physiologically acceptable excipient Methods for formulating a vaccine are within the scope of the present invention. |
priorityDate |
2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |